WARSAW, Ind., April 21, 2025 — Zimmer Biomet Holdings, Inc. (“Zimmer Biomet”; NYSE and SIX: ZBH), a global medical technology leader, today announced it has completed the acquisition of Paragon 28, Inc. (“Paragon 28”), a leading medical device company focused exclusively on the fast-growing foot and ankle orthopedic space. “We look forward to building on the strong foundation set by...
(WARSAW, Ind. and ENGLEWOOD, Colo.) January 28, 2025 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, Inc. (NYSE: FNA), a leading medical device company focused exclusively on the foot and ankle orthopedic segment, today announced they have entered into a definitive agreement for Zimmer Biomet to...
ENGLEWOOD, Colo.– Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of the Phantom® Fibula Nail System, designed to give surgeons a less invasive option to treat the fibula when patients sustain an ankle fracture. Use of a fibula nail for the treatment of ankle fractures has been shown to have significantly fewer...
ENGLEWOOD, Colo. – Paragon 28, Inc. (NYSE: FNA) is pleased to announce the addition of a novel Right-Angle Drill to the APEX 3D™ Total Ankle Replacement System designed to improve tibia preparation prior to the implantation of the APEX 3D™ tibia implant. The Right-Angle Drill utilizes a linear guide to precisely drill vertical holes into...
ENGLEWOOD, Colo.– Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of the R3FLEX™ Stabilization System, which is designed to restore stability to the ankle syndesmosis after injury from an ankle fracture or high ankle sprain. Figure 1: R3FLEX™ Stabilization System and Gorilla® Ankle Fracture Plating System used to treat an ankle fracture...
ENGLEWOOD, Colo. Paragon 28, Inc. (NYSE: FNA), is proud to announce the launch of the SMART28℠ Case Management Portal, a cutting-edge platform that leverages AI and a seamless user experience to coordinate patient-specific surgical plans. It is the first major launch of Paragon 28’s SMART28℠ ecosystem, a portfolio of solutions and products that drive Paragon...
ENGLEWOOD, Colo.– Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Chadi Chahine has been appointed Chief Financial Officer and Executive Vice-President of Supply Chain Operations, effective August 5, 2024. The Company also reported financial results for the quarter ended June 30,...
Launch of the Grappler® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high ankle sprains.
Paragon 28 announces the launch of the PRECISION® MIS Bunion System, which allows surgeons to complete a distal metatarsal osteotomy using a minimally invasive (MIS) surgical technique.
Paragon 28 is proud to announce the launch of its FJ2000™ Power Console and Burr System designed for a wide range of minimally invasive and open procedures.
The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.
© 2024 Paragon 28, Inc.
